Medicare Enrolled
Dr. Kashif Irfan, MD
Pain Medicine · Mesquite, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Irfan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Irfan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Irfan
Dr. Kashif Irfan is a pain medicine specialist in Mesquite, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Irfan performed 5,468 Medicare services across 1,045 unique beneficiaries.
Between the years covered by Open Payments, Dr. Irfan received a total of $25,616 from 71 pharmaceutical and/or device companies across 1076 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Irfan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in TX
$25,616 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,468
Medicare services
Top 11% in TX for pain medicine
1,045
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~273 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, propofol, 10 mg | 2,008 | $0 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
688 | $88 | $375 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
659 | $60 | $550 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
653 | $111 | $2,173 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
394 | $1 | $7 |
| Remote therapeutic monitoring, first 20 minutes Physician management of remote therapeutic monitoring data for the first 20 minutes per calendar month. |
155 | $39 | $300 |
| Remote therapeutic monitoring, additional 20 minutes This service covers the physician's time for managing remote therapeutic monitoring data beyond the initial monthly allotment. It applies for each additional 20-minute increment used within a calendar month. |
123 | $31 | $297 |
| Musculoskeletal remote monitoring device supply, 30 days A device supply that records and transmits data for remote monitoring of the musculoskeletal system over a 30-day period. |
120 | $39 | $272 |
| Physical therapy exercise, per 15 min A therapy session using exercises to improve strength, endurance, range of motion, and flexibility. Each 15-minute unit is billed separately. |
85 | $18 | $240 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $68 | $275 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
65 | $274 | $5,179 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
64 | $126 | $3,612 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
54 | $55 | $389 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
54 | $47 | $270 |
| Remote therapy monitoring setup and education This service involves setting up equipment and providing patient education for the remote monitoring of therapy. |
48 | $15 | $283 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
26 | $191 | $5,116 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
26 | $101 | $2,830 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
24 | $36 | $225 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $119 | $460 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
21 | $206 | $6,097 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
21 | $106 | $4,149 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
21 | $332 | $7,713 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
21 | $178 | $2,239 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
20 | $160 | $6,374 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
16 | $0 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$25,616
Total received (2018-2024)
Avg $3,659/year across 7 years
Top 9% in TX for pain medicine
71
Companies
1,076
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,580 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$36 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,568
2023
$2,970
2022
$2,397
2021
$3,623
2020
$2,862
2019
$4,187
2018
$4,009
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$3,284
Boston Scientific Corporation
$1,974
Medtronic, Inc.
$1,751
Collegium Pharmaceutical, Inc.
$1,346
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,244
Spinal Simplicity, LLC
$1,140
PFIZER INC.
$1,016
Daiichi Sankyo Inc.
$953
Biohaven Pharmaceuticals, Inc.
$883
Amgen Inc.
$883
Forte Bio-Pharma LLC
$857
Nevro Corp.
$672
Teva Pharmaceuticals USA, Inc.
$661
Horizon Therapeutics plc
$625
AbbVie Inc.
$600
Vertos Medical, Inc.
$527
SCILEX PHARMACEUTICALS INC.
$511
Medtronic USA, Inc.
$510
Scilex Pharmaceuticals Inc.
$496
ABBVIE INC.
$464
Curonix LLC
$424
BioDelivery Sciences International, Inc.
$382
Horizon Pharma plc
$338
Allergan Inc.
$254
Pacira Therapeutics, Inc.
$240
Biohaven Pharmaceutical Holding Company Ltd.
$237
GRT US Holding, Inc.
$216
Averitas Pharma Inc.
$192
Relievant Medsystems, Inc.
$190
Nuvectra Corporation
$183
Novartis Pharmaceuticals Corporation
$167
Zynex Medical, Inc.
$156
Flexion Therapeutics, Inc.
$148
BOSTON SCIENTIFIC CORPORATION
$129
US WorldMeds, LLC
$129
Acacia Pharma Inc
$124
Pacira Pharmaceuticals Incorporated
$122
ASSERTIO THERAPEUTICS, Inc.
$112
Vertiflex, Inc.
$111
IBSA Pharma Inc.
$86
Lilly USA, LLC
$85
MML US, Inc.
$84
Vertical Pharmaceuticals, LLC
$80
Azurity Pharmaceuticals, Inc.
$77
Almatica Pharma LLC
$74
Fidia Pharma USA Inc.
$72
Hikma Pharmaceuticals USA
$60
Arbor Pharmaceuticals, Inc.
$59
Genesys Orthopedics Systems, L.L.C.
$56
Epimed International, Inc
$54
Assertio Therapeutics, Inc.
$52
RedHill Biopharma Inc.
$50
Bioventus LLC
$40
Baudax Bio Inc.
$38
ARBOR PHARMACEUTICALS, INC.
$38
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$38
Valinor Pharma, LLC
$37
Avanos Medical
$34
AstraZeneca Pharmaceuticals LP
$31
Currax Pharmaceuticals LLC
$29
Allergan, Inc.
$28
Shionogi Inc
$26
VERTEX PHARMACEUTICALS INCORPORATED
$22
BAUDAX BIO INC.
$21
DePuy Synthes Sales Inc.
$20
UPSHER-SMITH LABORATORIES LLC
$19
PAINTEQ LLC
$17
Purdue Pharma L.P.
$13
Zyla Life Sciences, Inc.
$12
Pernix Therapeutics Holdings, Inc.
$12
FIDIA PHARMA USA INC.
$4
Top 3 companies account for 27.4% of total payments
Associated products mentioned in payments ›
ACCURIAN · AIMOVIG · AJOVY · ANJESO · Aimovig · Algovita · Axium INS DRG IPG · BARHEMSYS · BELBUCA · BOTOX · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · COMIRNATY · COSENTYX · Cambia · Catheters and Needles · DUEXIS · DUROLANE · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · ETERNA · Epidural needles and catheters · Exparel · FLECTOR · FREELINK · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERATOR · GRALISE · Gralise · HA MINUTEMAN G3-R · HYMOVIS · Horizant · Hymovis · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KRYSTEXXA · Kloxxado · LIBERTY SI · LICART · LORZONE · LUCEMYRA · LYRICA · Licart · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NALOCET · NAPRELAN · NURTEC ODT · Nalocet · Nexwave · Nucynta · ONZETRA XSAIL · Octrode SCS Leads · PAINTEQ · PAXLOVID · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Protege Family of SCS IPGs · QULIPTA · QUTENZA · Quattrode Leads SCS Leads · Qutenza · RAYOS · RELISTOR · RELISTOR ORAL · ReActiv8 · SCS leads · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRIX · SYMPROIC · Sacroiliac Joint Fusion System · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Symproic · TREXIMET · TRIVISC SODIUM HYALURONATE · Tirosint · UBRELVY · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZAVZPRET · ZEMBRACE SYMTOUCH · ZIPSOR · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for pain medicine in TX.
Equivalent to $468 per 100 Medicare services performed
Geographic Context
Pain medicines within 10 mi
82
Per 100K population
3.1
County median income
$74,149
Nearest hospital
DALLAS REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Irfan is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), with low-engagement industry engagement in the top 9% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Irfan experienced with injection, propofol, 10 mg?
Based on Medicare claims data, Dr. Irfan performed 2,008 injection, propofol, 10 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Irfan receive payments from pharmaceutical companies?
Yes. Dr. Irfan received a total of $25,616 from 71 companies across 1,076 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Irfan's costs compare to other pain medicines in Mesquite?
Dr. Irfan's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Irfan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Mesquite
Browse pain medicines in Mesquite ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in TX
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in TX
Which TX pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology